Josh Arnold Investment Consultant’s Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 CANO.WS Stock Holding History

Josh Arnold Investment Consultant’s Portfolio CANO.WS Stock Details CANO.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-363,132	Closed	-$254	–	28
2023 Q4	$254	Hold	363,132	–	–	﹤0.01%	24
2023 Q3	$14.7K	Hold	363,132	–	–	0.02%	24
2023 Q2	$76.3K	Buy	+363,132	New	+$91K	0.07%	27
2023 Q1	–	Sell	-511,200	Closed	-$112K	–	23
2022 Q4	$112K	Buy	+511,200	New	+$444K	0.16%	16
2022 Q3	–	Sell	-985,165	Closed	-$670K	–	19
2022 Q2	$670K	Buy	+985,165	New	+$1.02M	0.86%	7
2022 Q1	–	Sell	-10,200	Closed	-$24K	–	27
2021 Q4	$24K	Buy	+10,200	New	+$30.9K	0.02%	17

Josh Arnold Investment Consultant's CANO.WS Position: Q1 2024 in Review

Josh Arnold Investment Consultant sold out of Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 (CANO.WS) in Q1 2024, closing a stake of 363,132 shares — an estimated $254 sold.

Josh Arnold Investment Consultant first reported a position in CANO.WS in Q4 2021 and held it in 6 quarters. The position peaked at $670K in Q2 2022. 0 funds tracked by Wall St. Rank hold CANO.WS as of Q1 2024.

Josh Arnold Investment Consultant reported no remaining Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position as of Q1 2024 after selling out during the quarter.
Josh Arnold Investment Consultant sold 363,132 Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 shares in Q1 2024, an estimated $254.
Josh Arnold Investment Consultant first reported a position in Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 in Q4 2021 and held it in 6 quarters.
Josh Arnold Investment Consultant's Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 position peaked at $670K in Q2 2022.
0 funds tracked by Wall St. Rank held Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150 as of Q1 2024.

Based on Josh Arnold Investment Consultant's 13F filing for Q1 2024, filed 15 May 2024.